ACTRN12605000640606已完成3 期
Milrinone versus placebo infusion intraoperatively to prevent vasospasm during free flap surgery
Department of Anaesthesia, St Vincent's Hospital Melbourne0 个研究点目标入组 100 人开始时间: 2005年10月13日最近更新:
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 发起方
- 入组人数
- 100
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomised controlled trial
- 主要目的
- Treatment
- 盲法
- Blinded (masking used)
入排标准
- 年龄范围
- ot stated 至 ot stated（—）
- 性别
- All
入选标准
- •Elective patients for free flap surgery.Serious cardiac disease, stenotic or ischaemic cardiac disease and history of ventricular arrhythmias.Previous adverse reaction or allergy to milrinone.Renal impairment Cr > 0.15 mmol/L.
排除标准
- •Inability to give informed consent and patient refusal.
研究者
相似试验
已完成
不适用
Milrinone in status asthmaticusRespiratorybronchial asthmaPACTR201802002998973dramrsobhy50
已完成
不适用
Combined effect of Intraoperative drugs Milrinone- Terlipressin on blood loss during hepatic resection.CTRI/2022/11/047220PGIMER36
招募中
不适用
effect of nebulized milrinone and intravenous milrinone in patients with pulmonary hypertentioI27.2Pulmonary HTN.Other secondary pulmonary hypertensionIRCT20201104049266N1Ahvaz University of Medical Sciences16
尚未招募
Unknown
Difference in effects of Milrinone given through vein or as gaseous mixture to the lung to reduce pressure in right side of the heart, in patients with narrowing of valve opening between left sided chambers undergoing Valve Replacement SurgeryCTRI/2023/05/052607IPGMER and SSKM Hospital
进行中（未招募）
不适用
Administration of the approved drug milrinone via venous access to treat and to prevent vasospasmSAB-induced vasospasmEUCTR2009-016620-32-ATDept. of Neurological Surgery, Medical University of Vienna